Flecainide Acetate

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2245 publications

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

Journal: American journal of therapeutics

Published: June 19, 2026

Contemporary Management of Fetal Sustained Supraventricular Tachycardia guided by Prenatal Echocardiography.

Contemporary Management of Fetal Sustained Supraventricular Tachycardia guided by Prenatal Echocardiography.

Journal: Indian pacing and electrophysiology journal

Published: June 15, 2026

Fulminant flecainide intoxication in an adolescent: cardiogenic shock requiring VA-ECMO support.

Fulminant flecainide intoxication in an adolescent: cardiogenic shock requiring VA-ECMO support.

Journal: BMJ case reports

Published: June 12, 2026

When Rhythm Control Backfires: Flecainide-Precipitated Transient Cardiomyopathy in the Setting of Electrical Cardioversion.

When Rhythm Control Backfires: Flecainide-Precipitated Transient Cardiomyopathy in the Setting of Electrical Cardioversion.

Journal: Cureus

Published: May 07, 2026

Severe flecainide poisoning successfully treated with lipid emulsion

Severe flecainide poisoning successfully treated with lipid emulsion

Journal: Revue medicale de Liege

Published: April 16, 2026

Refractory Atrial Tachycardia and Ivabradine in a Case of Catecholaminergic Polymorphic Ventricular Tachycardia.

Refractory Atrial Tachycardia and Ivabradine in a Case of Catecholaminergic Polymorphic Ventricular Tachycardia.

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: April 10, 2026

Novel RYR2-A4510T Variant Presenting Both as Autosomal Dominant and Autosomal Recessive Catecholaminergic Polymorphic Ventricular Tachycardia.

Novel RYR2-A4510T Variant Presenting Both as Autosomal Dominant and Autosomal Recessive Catecholaminergic Polymorphic Ventricular Tachycardia.

Journal: Circulation. Genomic and precision medicine

Published: April 10, 2026

A simple, high-throughput LC-MS/MS method for the simultaneous quantification of four antiarrhythmic drugs and two metabolites: large-scale application to 622 patient samples.

A simple, high-throughput LC-MS/MS method for the simultaneous quantification of four antiarrhythmic drugs and two metabolites: large-scale application to 622 patient samples.

Journal: Talanta

Published: April 05, 2026

Flecainide in Structural Heart Disease: Reconsidering Its Role in Contemporary Arrhythmia Management.

Flecainide in Structural Heart Disease: Reconsidering Its Role in Contemporary Arrhythmia Management.

Journal: Life (Basel, Switzerland)

Published: April 01, 2026

Short-Coupled Purkinje Ventricular Fibrillation Triggers Successfully Suppressed With Flecainide.

Short-Coupled Purkinje Ventricular Fibrillation Triggers Successfully Suppressed With Flecainide.

Journal: JACC. Case reports

Published: March 27, 2026

The present and future of antiarrhythmic drugs.

The present and future of antiarrhythmic drugs.

Journal: JRSM cardiovascular disease

Published: February 23, 2026

The Frontal QRS-T Angle Remains Unchanged in Patients Without Structural Heart Disease Receiving Flecainide Therapy.

The Frontal QRS-T Angle Remains Unchanged in Patients Without Structural Heart Disease Receiving Flecainide Therapy.

Journal: Journal of cardiovascular development and disease

Published: February 19, 2026

Showing 1-12 of 2,245

Last Updated: 06/30/2026